See original release here Government of Canada supports research and development of miniature probe for medical application Development of an imaging and tissue cutting probe for guided neuro surgeries is expected to improve patient survival rates and create 12 highly-skilled positions in Nova Scotia’s life sciences sector. This includes nine placements for graduate students to…

For Immediate Release February 17, 2017 – HALIFAX, Nova Scotia –– Appili Therapeutics Inc.(“Appili”), an anti-infective drug development company, announced today that it will be receiving $2,803,148 from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF). This funding will enable Appili to take its first drug, ATI-1501 – a taste-masked, oral…

TAP allows life sciences SMEs to apply for small project funding to engage technical expertise that is not available within their company. The technical expertise received is intended to allow the company to overcome an immediate challenge that is acting as a barrier to commercialization.

See original release here HALIFAX, Nova Scotia – February 14, 2017 — Kinduct Technologies, a data and analytics software provider, and Athletigen Technologies Inc., a leader in proprietary human performance insights and genetic analytics provider, today announced that Kinduct’s software platform will soon incorporate Athletigen’s genetic insights. “The partnership with Kinduct is an exciting opportunity,…

See full story by Sara Ericsson in Queens County Advance CORNWALLIS, N.S. – Nova Scotia’s provincial government has announced funding for internships in research and innovation aimed at creating work opportunities for Nova Scotia students and companies. It was announced Feb. 6 at Acadian Seaplants in Cornwallis that $705,000 in funding will create 170 internships over…

Original Press Release University Health Network (UHN) in Toronto to Launch Triple-Combination Study Evaluating the Potential for Enhanced Anti-Cancer Activity of Currently Marketed Checkpoint Inhibitor When Combined with DPX-Survivac  Halifax, Nova Scotia; February 6, 2017 – Immunovaccine Inc. (TSX: IMV; OTCQX: IMMVF), a clinical stage immuno-oncology company, today announced that the UHN’s Princess Margaret Cancer…

2015 © Copyright - Bionova